bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case
Go back to bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case| (NASDAQ: BIAF) | Delayed: 0.84 +0.01 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.83 | 52 Week High | $ | |||
| Open | $0.84 | 52 Week Low | $ | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $ | |||
| Volume | 827,387 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $ | |||
| Open | $0.14 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.14 | EPS | $ | |||
| Volume | 139 | |||||

